Higher hepatic ANGPTL3 expression resulted in higher plasma ANGPTL3 levels, which were positively associated with clinical/histological markers of NAFLD/NASH. The gene discussed is ANGPTL3; the disease is metabolic dysfunction-associated steatohepatitis.